Personal Experience with Psoriatic Arthritis and Atopic Dermatitis – Medriva

Personal Experience with Psoriatic Arthritis

Maarten de Wit, diagnosed with Psoriatic Arthritis (PsA) during his teenage years, has firsthand experience of the difficulties involved in diagnosing PsA, especially in younger patients. PsA is a chronic inflammatory disease primarily characterized by plaque psoriasis but also has less common variants. It can lead to various comorbidities such as metabolic syndrome, cardiovascular disease, and mental health disorders. Despite the prevalence of PsA, affecting approximately 3% of the US population and causing an estimated healthcare expenditure of over 35 billion annually, its diagnosis is often complex and challenging.

To combat these challenges, the HIPPOCRATES project aims to improve PsA detection and prevent its onset. Similarly, the BIOMAP project seeks to understand and classify PsA and Atopic Dermatitis (AD) subtypes. Both projects utilize advanced molecular techniques in their pursuit of developing more effective treatments.

Atopic Dermatitis (AD) is another skin condition that requires attention, with numerous studies and articles discussing its treatment strategies, patient management, and potential therapeutic avenues. While conventional treatment methods have shown efficacy, managing patients with AD remains a challenge due to varying patient responses and the complex nature of the disease.

Genomic testing in dermatology is emerging as a promising approach to improve medical diagnoses and treatment. It explores the entire genome, including genetic and epigenetic factors, and has made significant advancements in analyzing skin microbiome and mutational analyses of inherited skin diseases. Genomic tests have emerged for various skin conditions like pigmented lesions, melanoma, and cutaneous squamous cell carcinoma and have also expanded into inflammatory skin diseases, offering insights through tape strips for AD and psoriasis.

Recent research has pointed towards a strong connection between gut health and dermatological diseases. The gut microbiome, consisting of over 1014 microorganisms, plays a significant role in human health. Dysbiosis, or imbalance in the gut microbiome, has been strongly associated with AD, psoriasis, acne, and alopecia areata. This has led to the examination of probiotics to correct gut microbiome dysbiosis as a potential treatment avenue for skin diseases.

While the diagnosis and treatment of PsA and AD continue to pose challenges, advancements in molecular techniques, genomic testing, and understanding the role of gut health in skin diseases are paving the way for more accurate diagnosis and effective treatment strategies. Initiatives like the HIPPOCRATES and BIOMAP projects are making strides in understanding these diseases at a molecular level, bringing hope for patients suffering from these conditions.

Read more:
Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva